VC
PFE icon

Vicus Capital’s Pfizer PFE Stock Holding History

Vicus Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$270K Sell
9,629
-765
-7% -$20.4K 0.02% 224
2025
Q4 		$259K Sell
10,394
-1,710
-14% -$43.1K 0.02% 232
2025
Q3 		$308K Buy
12,104
+1,828
+18% +$45.1K 0.02% 219
2025
Q2 		$249K Sell
10,276
-1,363
-12% -$31.8K 0.02% 241
2025
Q1 		$295K Buy
11,639
+1,059
+10% +$27.7K 0.03% 191
2024
Q4 		$281K Buy
10,580
+3,173
+43% +$86.1K 0.02% 187
2024
Q3 		$214K Sell
7,407
-800
-10% -$23.3K 0.02% 207
2024
Q2 		$230K Sell
8,207
-260
-3% -$7.16K 0.02% 250
2024
Q1 		$235K Sell
8,467
-410
-5% -$11.4K 0.02% 247
2023
Q4 		$256K Sell
8,877
-4,940
-36% -$149K 0.03% 181
2023
Q3 		$458K Buy
13,817
+1,039
+8% +$36.7K 0.05% 154
2023
Q2 		$469K Sell
12,778
-1,167
-8% -$45.4K 0.05% 137
2023
Q1 		$569K Sell
13,945
-145
-1% -$6.26K 0.06% 126
2022
Q4 		$722K Sell
14,090
-2,194
-13% -$105K 0.08% 104
2022
Q3 		$713K Sell
16,284
-875
-5% -$42.5K 0.08% 120
2022
Q2 		$900K Buy
17,159
+456
+3% +$23.2K 0.1% 105
2022
Q1 		$865K Sell
16,703
-1,390
-8% -$72.1K 0.09% 114
2021
Q4 		$956K Buy
+18,093
New +$896K 0.1% 108
2021
Q2 		– Sell
-24,899
Closed -$902K – 222
2021
Q1 		$902K Sell
24,899
-4,695
-16% -$167K 0.11% 107
2020
Q4 		$1.09M Sell
29,594
-2,863
-9% -$105K 0.13% 82
2020
Q3 		$1.13M Sell
32,457
-3,039
-9% -$107K 0.16% 69
2020
Q2 		$1.1M Buy
35,496
+1,190
+3% +$40.4K 0.17% 73
2020
Q1 		$1.06M Buy
34,306
+310
+0.9% +$10.6K 0.2% 70
2019
Q4 		$1.26M Sell
33,996
-1,164
-3% -$41.5K 0.19% 70
2019
Q3 		$1.2M Sell
35,160
-2,761
-7% -$100K 0.17% 91
2019
Q2 		$1.56M Sell
37,921
-2,827
-7% -$112K 0.22% 73
2019
Q1 		$1.64M Sell
40,748
-3,214
-7% -$129K 0.26% 65
2018
Q4 		$1.82M Sell
43,962
-595
-1% -$24.7K 0.32% 59
2018
Q3 		$1.86M Buy
44,557
+1,455
+3% +$56K 0.3% 57
2018
Q2 		$1.48M Buy
43,102
+7,626
+21% +$261K 0.24% 65
2018
Q1 		$1.2M Buy
35,476
+10,732
+43% +$369K 0.21% 79
2017
Q4 		$850K Buy
24,744
+5,374
+28% +$183K 0.15% 108
2017
Q3 		$656K Buy
19,370
+5,029
+35% +$162K 0.13% 126
2017
Q2 		$457K Buy
14,341
+1,842
+15% +$58.1K 0.09% 148
2017
Q1 		$406K Sell
12,499
-13,479
-52% -$425K 0.09% 157
2016
Q4 		$801K Buy
25,978
+15,990
+160% +$488K 0.18% 104
2016
Q3 		$321K Buy
9,988
+832
+9% +$27.8K 0.07% 167
2016
Q2 		$306K Sell
9,156
-3,644
-28% -$116K 0.07% 148
2016
Q1 		$360K Buy
12,800
+3,791
+42% +$108K 0.08% 131
2015
Q4 		$276K Buy
9,009
+1,352
+18% +$42.5K 0.07% 161
2015
Q3 		$228K Buy
+7,657
New +$246K 0.06% 153
2015
Q2 		– Sell
-5,965
Closed -$197 – 196
2015
Q1 		$197 Buy
+5,965
New +$190K 0.04% 173
2014
Q2 		– Sell
-6,871
Closed -$209K – 169
2014
Q1 		$209K Buy
+6,871
New +$205K 0.07% 130

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Vicus Capital's PFE Position: Q1 2026 in Review

Vicus Capital reduced its Pfizer (PFE) stake by 7.4% in Q1 2026, selling an estimated $20.4K and leaving 9,629 shares worth $270K. The position accounts for 0.02% of the portfolio, ranked #224.

Vicus Capital first reported a position in PFE in Q1 2014 and has held it in 43 quarters since. The position peaked at $1.86M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Vicus Capital held 9,629 shares of Pfizer worth $270K as of Q1 2026.
  • Vicus Capital sold 765 Pfizer shares in Q1 2026, an estimated $20.4K.
  • Pfizer made up 0.02% of Vicus Capital's portfolio in Q1 2026, its #224 holding.
  • Vicus Capital first reported a position in Pfizer in Q1 2014 and has held it in 43 quarters since.
  • Vicus Capital's Pfizer position peaked at $1.86M in Q3 2018.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.